logo

Mannkind Corp. (MNKD)



Trade MNKD now with
  Date
  Headline
11/7/2017 4:02:17 PM MannKind Q3 Net Loss $32.9 Mln Or $0.31 Per Share
10/23/2017 7:05:25 AM MannKind Announces Submission Of Registration Dossier To ANVISA Seeking Approval Of Afrezza In Brazil
10/11/2017 12:08:11 AM MannKind Announces Registered Direct Offering Of 10.17 Mln Common Stock At $6/Shr
10/2/2017 6:08:20 AM MannKind Says FDA Approves An Update To Afrezza Prescribing Information